v3.25.0.1
Fourth Quarter Financial Results (unaudited)
12 Months Ended
Dec. 31, 2024
Quarterly Financial Information Disclosure [Abstract]  
Fourth Quarter Financial Results (unaudited) Fourth Quarter Financial Results (unaudited)
quarter ended December 31 (in millions except per share data)2024
Net revenues$15,102 
Gross margin10,706 
Net loss attributable to AbbVie Inc.
(22)
Basic loss per share attributable to AbbVie Inc.$(0.02)
Diluted loss per share attributable to AbbVie Inc.$(0.02)
Cash dividends declared per common share$1.64